117 Anti-TIF-1 antibody positivity is associated with a five-fold increase in cancer risk in the idiopathic inflammatory myopathies
Alexander Oldroyd(Manchester Academic Health Science Centre), Hector Chinoy(Salford Royal NHS Foundation Trust), Jamie C. Sergeant(Manchester Academic Health Science Centre), Neil McHugh(University of Bath), Janine A. Lamb(University of Manchester), Paul New(University of Liverpool), William Ollier(University of Manchester), Zoë Betteridge(University of Bath), Robert G. Cooper(McMaster University)
Cited by 0
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence
|Nature Genetics|2017|518
Erratum: Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence
|Nature Genetics|2017|376
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
|Neuromuscular Disorders|2019|308